Literature DB >> 18095319

Characteristics and survival of 750 children diagnosed with a renal tumor in the first seven months of life: A collaborative study by the SIOP/GPOH/SFOP, NWTSG, and UKCCSG Wilms tumor study groups.

Marry M van den Heuvel-Eibrink1, Paul Grundy, Norbert Graf, Kathy Pritchard-Jones, Christophe Bergeron, Catherine Patte, Harm van Tinteren, Annie Rey, Carolyn Langford, Jim R Anderson, Jan de Kraker.   

Abstract

BACKGROUND: To review the clinical characteristics and survival of infants diagnosed with a primary renal tumor in the first 7 months of life. PROCEDURE: A retrospective data review of patients registered in five large international protocols (SFOP/GPOH/SIOP9/93-01, UKW3 and NWTSG 4 and 5) spanning 1985-2002.
RESULTS: 750 (7.2%) of 10,430 registered patients were diagnosed with a renal tumor before age 213 days. Tumor types were Wilms tumor (WT) 58%; congenital mesoblastic nephroma (CMN) 18%; malignant rhabdoid tumor (MRTK) 8%; clear cell sarcoma (CCSK) 2%; non-Wilms tumor (unspecified) 6%; histology unknown, 9%. CMN predominated among tumors diagnosed in the first month of life (54%) but its relative contribution diminished to <10% of all cases diagnosed after the age of 3 months (P < 0.001). Among 639 cases with specified histology and stage, 9/11 stage IV tumors were MRTK, 37/39 bilateral tumors were WT. In 626 children where surgical approach was specified, 522 had immediate nephrectomy. For all cases, 5 years event-free survival (EFS) was 80% and overall survival (OS) 86%. Five years EFS and OS respectively by tumor type were WT (86%, 93%), CMN (94%, 96%), CCSK (49%, 51%), MRTK (16%, 16%).
CONCLUSION: Renal tumors diagnosed in the first 7 months of life generally have an excellent prognosis though histology is an important prognostic factor. In the first 2 months of life the prevalence of CMN is high. The relative occurrence of WT increases rapidly with age thereafter. Bilateral tumors are usually WT. Tumors with metastases at diagnosis are usually MRTK. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18095319     DOI: 10.1002/pbc.21389

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  21 in total

1.  Regression of a congenital mesoblastic nephroma.

Authors:  Sarah Whittle; Ankush Gosain; Petagay Y Scott Brown; Lairsa Debelenko; Susana Raimondi; Judith A Wilimas; Jesse J Jenkins; Andrew M Davidoff
Journal:  Pediatr Blood Cancer       Date:  2010-08       Impact factor: 3.167

Review 2.  Position paper: Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol.

Authors:  Marry M van den Heuvel-Eibrink; Janna A Hol; Kathy Pritchard-Jones; Harm van Tinteren; Rhoikos Furtwängler; Arnauld C Verschuur; Gordan M Vujanic; Ivo Leuschner; Jesper Brok; Christian Rübe; Anne M Smets; Geert O Janssens; Jan Godzinski; Gema L Ramírez-Villar; Beatriz de Camargo; Heidi Segers; Paola Collini; Manfred Gessler; Christophe Bergeron; Filippo Spreafico; Norbert Graf
Journal:  Nat Rev Urol       Date:  2017-10-31       Impact factor: 14.432

Review 3.  Imaging of solid congenital abdominal masses: a review of the literature and practical approach to image interpretation.

Authors:  Krista L Birkemeier
Journal:  Pediatr Radiol       Date:  2020-11-30

4.  The diagnostic accuracy and clinical utility of pediatric renal tumor biopsy: Report of the UK experience in the SIOP UK WT 2001 trial.

Authors:  Thomas J Jackson; Richard D Williams; Jesper Brok; Tanzina Chowdhury; Milind Ronghe; Mark Powis; Kathy Pritchard-Jones; Gordan M Vujanić
Journal:  Pediatr Blood Cancer       Date:  2019-02-13       Impact factor: 3.167

Review 5.  Is Pre-operative Chemotherapy Desirable in all Patients of Wilms' Tumor?

Authors:  Akash Kumar; Sameer Bakhshi; Sandeep Agarwala
Journal:  Indian J Pediatr       Date:  2017-07-08       Impact factor: 1.967

Review 6.  Pediatric genitourinary tumors.

Authors:  Sharon M Castellino; Anibal R Martinez-Borges; Thomas W McLean
Journal:  Curr Opin Oncol       Date:  2009-05       Impact factor: 3.645

7.  K-Ras, H-Ras, N-Ras and B-Raf mutation and expression analysis in Wilms tumors: association with tumor growth.

Authors:  Efterpi Dalpa; Victor Gourvas; Nikolaos Soulitzis; Demetrios A Spandidos
Journal:  Med Oncol       Date:  2016-12-09       Impact factor: 3.064

Review 8.  Malignant tumours of the kidney: imaging strategy.

Authors:  Anne M Smets; Jan de Kraker
Journal:  Pediatr Radiol       Date:  2010-04-30

Review 9.  Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration.

Authors:  Jeffrey S Dome; Norbert Graf; James I Geller; Conrad V Fernandez; Elizabeth A Mullen; Filippo Spreafico; Marry Van den Heuvel-Eibrink; Kathy Pritchard-Jones
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

Review 10.  Imaging of Wilms tumor: an update.

Authors:  Sabah E Servaes; Fredric A Hoffer; Ethan A Smith; Geetika Khanna
Journal:  Pediatr Radiol       Date:  2019-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.